| Literature DB >> 35089872 |
Cora Braat1, Gerda M Verduijn, Heleen A van der Stege, Marinella P J Offerman, Mariëlle A C Peeters, AnneLoes van Staa, Wendy H Oldenmenger.
Abstract
BACKGROUND: The supportive needs for head and neck cancer (HNC) patients during the vulnerable period after treatment are not always met. Therefore, more professional support regarding physical, social, and psychological care as well as lifestyle is recommended.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35089872 PMCID: PMC7612389 DOI: 10.1097/NCC.0000000000000983
Source DB: PubMed Journal: Cancer Nurs ISSN: 0162-220X Impact factor: 2.760

Figure 2Self-Management Web
Figure 3Flowchart inclusion
Background Variables and Disease Characteristics
|
| 62 (42-71) | 62 (50-72) |
|
| 23 (85) | 18 (64) |
|
| ||
|
| 5 (19%) | 9 (32%) |
|
| 16 (59%) | 19 (68%) |
|
| 6 (22%) | 0 |
|
| ||
|
| 1 (4%) | 4 (14%) |
|
| 13 (48%) | 12 (43%) |
|
| 11 (41%) | 10 (36%) |
|
| 1 (4%) | 2 (7%) |
|
| 1 (4%) | 0 |
|
| ||
|
| 19 (90%) | 23 (82%) |
|
| 2 (10%) | 5 (18%) |
IMRT= Intensity-modulated radiotherapy
CDDP= Cisplatin
Outcome Measurements
| Intervention Group | Intervention Group | Historical Control Group | p-value | Effect Size | ||||
|---|---|---|---|---|---|---|---|---|
| T0, n=26 | T1, n=21* | N=27 | CG-IG | IG | CG-IG | |||
| Median (IQR) | Median (IQR) | Median (IQR) | T0-T1 | T1 | ||||
|
| ||||||||
|
| 79.2 (66.7-91.7) | 83.3 (66.7-95.8) | 83.3 (66.7-91.7) | .86 | .11 | .01 | ||
|
| 93.3 (80.0-100) | 93.3 (86.7-100) | 86.7 (73.3-100) | .17 | .32 | .41 | ||
|
| 83.3 (66.7-100) | 83.3 (50.0-100) | 100 (70.8-100) | .19 | -.04 | -.52 | ||
|
| 87.5 (66.7-100) | 91.7 (62.5-91.7) | 83.3 (66.7-100) | .99 | .05 | .14 | ||
|
| 100 (83.3-100) | 100 (91.7-100) | 83.3 (66.7-100) |
| .27 | .54 | ||
|
| 83.3 (66.7-100) | 100 (66.7-100) | 83.3 (66.7-100) | .94 | .12 | .13 | ||
|
| 12.8 (5.1-24.4) | 9.0 (1.9-15.4) | 10.3 (5.1-23.1) | .53 | -.48 | -.31 | ||
|
| ||||||||
|
| 16.7 (8.3-41.7) | 8.3 (8.3-22.9) | 12.5 (0-27.1) | .97 | -.51 | -.18 | ||
|
| 8.3 (0-33.3) | 4.2 (0-16.7) | 16.7 (0-43.8) | .16 | -.24 | -.43 | ||
|
| 25.0 (12.5-33.3) | 16.7 (8.3-33.3) | 33.3 (0-50.0) | .42 | -.24 | -.34 | ||
|
| 22.2 (11.1-33.3) | 11.1 (11.1-27.8) | 11.1 (0-33.3) | .78 | -.06 | .12 | ||
|
| 16.7 (8.3-41.7) | 8.3 (0-25.0)
| 29.2 (2.1-50.0) | .08 | -.47 | -.61 | ||
|
| 0 (0-6.7) | 0 (0-6.7) | 0 (0-11.7) | .85 | -.02 | 0 | ||
|
| 16.7 (0-58.3) | 0 (0-33.3) | 0 (0-33.3) | .85 | -.35 | -.15 | ||
|
| 0 (0-33.3) | 0 (0-0) | 0 (0-33.3) | .051 | -.64 | .60 | ||
|
| 0 (0-33.3) | 0 (0-33.3) | 0 (0-66.7) | .47 | .22 | -.25 | ||
|
| 66.7 (33.3-66.7) | 33.3 (33.3-66.7) | 66.7 (33.3-100) | .54 | -.75 | -.18 | ||
|
| 33.3 (33.3-75.0) | 33.3 (0-50.0)
| 33.3 (0-66.7) | .67 | -.65 | -.22 | ||
|
| 33.3 (33.3-66.7) | 33.3 (0-33.3) | 33.3 (0-33.3) | .51 | -.33 | .12 | ||
|
| 0 (0-33.3) | 0 (0-33.3) | 0 (0-0) | .14 | .05 | .32 | ||
|
| ||||||||
|
| 6.6 (6.0-7.5) | 7.0 (6.1-7.6) | 6.9 (5.9-6.9) | .35 | .29 | .18 | ||
|
| 7.4 (5.8-7.7) | 6.9 (5.4-8.0) | 7.6 (6.4-8.0) | .58 | -.28 | -.38 | ||
|
|
| 5.5 (3.4-7.3) | 7.0 (4.8-9.2) | 6.7 (4.0-8.0) | .26 | -.15 | .29 | |
|
| 4.0 (3.8-4.0) | 4.0 (3.5-4.0) | 4.0 (3.6-4.0) | .708 | .62 | .35 | ||
IQR=InterQuartileRange;
EORTC QLQ C30: no significant differences within the IG;
IG T0-T1: p=.004;
IG T0-T1: p=.095;
IG T0-T1: p=.045;
IG T0-T1: p=.022;
CAHPS=Consumer Assessment of Health Plan Surveys. PIH=Partners in Health Scale; SECD6= Self-Efficacy for Managing Chronic Disease 6-item Scale.
Figure 4Importance of Paying Attention and Actual Paid Attention of the Domains of Care